A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies. [electronic resource]
- Clinical trials (London, England) 2008
- 465-77 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1740-7745
10.1177/1740774508096474 doi
Algorithms Biomarkers--analysis Clinical Trials, Phase I as Topic--methods Dose-Response Relationship, Drug Drug-Related Side Effects and Adverse Reactions Humans